SARM1 inhibitors might backfire: perfect Wallerian degeneration timing matters more than axon preservation

We are chasing SARM1 inhibitors to slow axonal breakdown after nerve injury—but what if slowing Wallerian degeneration actually hurts recovery? Mice with delayed degeneration (WldS mutants) show worse long-term regeneration, suggesting there is a narrow window where Schwann cells need to clear debris and transform. Preservation without the cleanup sequence may leave axons wandering through a nerve stump that is not ready for them.